Corcept Therapeutics (CORT) Amortizatization of Intangibles (2012 - 2017)
Corcept Therapeutics (CORT) reported Amortizatization of Intangibles of $44000.0 for Q4 2017, down 88.01% on a YoY basis from $367000.0 in Q4 2016, and up 18.92% sequentially from $37000.0 in Q3 2017.
Corcept Therapeutics (CORT) Amortizatization of Intangibles (2012 - 2017) Analysis & Trends
Corcept Therapeutics (CORT) has 6 years of Amortizatization of Intangibles data on file, last reported at $44000.0 in Q4 2017.
- For the quarter ending Q4 2017, Amortizatization of Intangibles fell 88.01% year-over-year to $44000.0; the trailing twelve-month figure through Dec 2017 stood at $500000.0 (down 74.08% YoY), and the FY2025 full-year result was $5.1 million, down 53.35% from the prior year.
- Amortizatization of Intangibles rose to $44000.0 in Q4 2017, from $37000.0 in the prior quarter.
- In the past five years, Amortizatization of Intangibles ranged from a high of $5.0 million in Q3 2013 to a low of $37000.0 in Q3 2017.
- A 5-year average of $946300.0 and a median of $717500.0 in 2015 frame the typical range for Amortizatization of Intangibles.
- Across the five-year window, Amortizatization of Intangibles fell 3.17% in 2013 and tumbled 91.87% in 2017, its largest moves.
- Tracing CORT's Amortizatization of Intangibles over 5 years: stood at $1.1 million in 2013, then dropped by 24.86% to $804000.0 in 2014, then dropped by 18.91% to $652000.0 in 2015, then sank by 43.71% to $367000.0 in 2016, then tumbled by 88.01% to $44000.0 in 2017.
- Business Quant data shows CORT's Amortizatization of Intangibles at $44000.0 in Q4 2017, $37000.0 in Q3 2017, and $149000.0 in Q2 2017.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | - |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | 3.22 Mn |
| 10 | Corcept Therapeutics | 9.99 Bn | 9.65 Bn | 162.02 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2017 | 44,000.00 |
| Dec 31, 2017 | 44,000.00 |
| Sep 30, 2017 | 37,000.00 |
| Sep 30, 2017 | 37,000.00 |
| Jun 30, 2017 | 149,000.00 |
| Jun 30, 2017 | 149,000.00 |
| Mar 31, 2017 | 270,000.00 |
| Mar 31, 2017 | 270,000.00 |
| Dec 31, 2016 | 367,000.00 |
| Dec 31, 2016 | 367,000.00 |
| Sep 30, 2016 | 455,000.00 |
| Sep 30, 2016 | 455,000.00 |
| Jun 30, 2016 | 523,000.00 |
| Jun 30, 2016 | 523,000.00 |
| Mar 31, 2016 | 584,000.00 |
| Mar 31, 2016 | 584,000.00 |
| Dec 31, 2015 | 652,000.00 |
| Dec 31, 2015 | 652,000.00 |
| Sep 30, 2015 | 698,000.00 |
| Sep 30, 2015 | 698,000.00 |